The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sun Pharmaceutical Industries, Inc. with a potential value of $8 million. The BPA is for the delivery of radiopharmaceutical dose products and consumables to support nuclear medicine services through January 2025. No set-asides were applied to this procurement. The original solicitation sought a contractor to provide radiopharmaceuticals and related supplies necessary for diagnostic imaging and therapeutic...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a single-award, indefinite delivery contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for radiopharmaceuticals. The contract has a potential value of $638,068.78 and period of performance through April 30, 2025. Associated delivery orders include a $212,636.63 firm fixed-price order for radiopharmaceuticals with performance in Orlovista,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA-VHA) awarded a blanket purchase agreement to Jubilant Draximage Radiopharmacies, Inc. doing business as Jubilant Radiopharma for the provision of radiopharmaceutical supplies. Under the single award agreement, which has a potential value of $1,379,724.67 and expires on March 31, 2028, the contractor may receive delivery orders for radiopharmaceuticals through April 30, 2024. The first...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a single award indefinite delivery contract to Advanced Accelerator Applications USA Inc. to provide radiopharmaceutical services and support. The contract has a potential value of $483,000 and period of performance through September 30, 2022. No set-aside was used for this award. Under the contract, the prime contractor has been issued two delivery orders. The first was for an...
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a ceiling value of $4,998,603.38 and a performance period through September 17, 2029. The contract is for the provision of critical radiopharmaceuticals used in nuclear medicine diagnostic services at VA medical centers and military treatment facilities, including gallium-67,...
The U.S. Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $6,977,655.70 to Mid-America Isotopes, Inc., a small disadvantaged business manufacturer of radiopharmaceuticals. The contract, which does not have a small business set-aside, is for the provision of "UNIT RADIOPHARMACEUTICALS" to support VA healthcare operations through September 2029. Under this IDC, the VA-VHA has...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded an indefinite delivery contract to Medi-Physics, Inc. to provide radiopharmaceuticals in support of nuclear medicine services. No set-aside provisions were applied. The contract includes a potential value of $633,955.36 over its period of performance from March 1, 2020 through February 28, 2023. Delivery orders issued against the contract include $214,344.50 awarded on March 1, 2022...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a single-award, indefinite delivery contract to Cardinal Health, Inc. for radiopharmaceutical products. The potential value of the contract is $773,677.24 with a period of performance from February 22, 2022 to February 21, 2023. Under this contract, Cardinal Health will provide radiopharmaceuticals to support medical imaging procedures for patients within the VA healthcare system....
The Defense Health Agency awarded RLS USA Inc. a single award indefinite delivery contract for radiopharmaceuticals with a potential value of $1,914,116.40 over five years. No set-aside provisions were applied. Under this vehicle, RLS USA Inc. received a firm fixed price delivery order for $299,975.67 to supply unspecified radiopharmaceutical products to the Defense Health Agency from their Tampa, Florida facility between November 2022 through September 2023. Additionally, a $64,238.93 order was...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 21 has awarded an Indefinite Delivery Contract (IDC) worth up to $1,200,000 to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, to provide radiopharmaceuticals and related supplies to VA medical centers and military treatment facilities. The initial task order under this IDC is valued at $179,605.38 and covers the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18,...